Table 1.
Comparison of clinical characteristics among the control group, the NAFLD group, and the NAFLD+CAD group.
| Indicators | Control | NAFLD | CAD+NAFLD | P |
|---|---|---|---|---|
| Cases (male/female) | 149 (75/74) | 113 (59/54) | 75 (38/37) | 0.927 |
| Ages (years) | 50.80 ± 12.15 | 50.93 ± 2.75 | 52.27 ± 4.06 | 0.442 |
| BMI (kg/m2) | 23.75 ± 3.56 | 26.44 ± 2.53 | 25.17 ± 2.56 | <0.001 |
| GLU (mmol/L) | 4.56 (1.11) | 4.84 (0.67) | 5.32 (1.43) | <0.001 |
| TBIL (μmol/L) | 13.17 ± 5.36 | 13.02 ± 4.65 | 14.33 ± 7.20 | 0.242 |
| ALT (U/L) | 17.66 (11.16) | 23.62 (21.20) | 22.63 (18.03) | <0.001 |
| AST (U/L) | 20.71 (6.44) | 21.64 (7.44) | 20.96 (18.43) | 0.141 |
| GGT (U/L) | 19.59 (14.54) | 32.55 (27.24) | 25.15 (16.65) | <0.001 |
| ALP (U/L) | 73.99 ± 23.58 | 70.26 ± 17.35 | 85.67 ± 21.83 | <0.001 |
| TG (mmol/L) | 1.11 (0.75) | 1.67 (1.17) | 1.46 (1.21) | 0.031 |
| TC (mmol/L) | 3.47 ± 0.80 | 5.51 ± 0.84 | 4.47 ± 1.19 | <0.001 |
| LDL-C (mmol/L) | 2.06 ± 0.56 | 3.27 ± 0.59 | 2.68 ± 0.92 | <0.001 |
| HDL-C (mmol/L) | 1.33 ± 0.48 | 1.23 ± 0.21 | 1.05 ± 0.28 | <0.001 |
Control: healthy control; NAFLD: nonalcoholic fatty liver disease; NAFLD+CAD: NAFLD patients with coronary artery disease. The data of normal distribution were expressed as mean ± SD; the data of nonnormal distribution were expressed as median (interquartile range). BMI: body mass index; GLU: glucose; TBIL: total bilirubin; ALT: alanine aminotransferase; AST: aspartate aminotransferase; GGT: γ-glutamyl transferase; ALP: alkaline phosphatase; TG: triglyceride; TC: total cholesterol; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol.